• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Immunomodulatory drugs (natalizumab), worsening of multiple sclerosis, rebound effect and similitude.
CONCLUSION: Relapses of MS after discontinuation of natalizumab treatment indicate rebound of disease activity, supporting the homeopathic principle and warning healthcare professionals about this serious iatrogenic event. PMID: 23870382 [PubMed - in process]
Source: Homeopathy - July 1, 2013 Category: Complementary Medicine Authors: Teixeira MZ Tags: Homeopathy Source Type: research

The use of traditional and complementary medicine among patients with multiple sclerosis in Belgium.
Conclusion. Patients diagnosed with MS seek hope in T&CM such as homeopathy or acupuncture. The results of this study suggest that MS patients need more professional support in their personal search for alternative therapies. Key point. 50% of patients diagnosed with multiple sclerosis search relief in traditional and complementary medicine such as homeopathy or acupuncture. These patients often feel compelled to try every opportunity to heal, often stimulated or urged on by friends or relatives. Multiple sclerosis patients are more satisfied with their conventional treatment than with the traditional and complementary...
Source: Journal of Medicine and Life - August 25, 2018 Category: General Medicine Tags: J Med Life Source Type: research

The role of multiple sclerosis therapies on the dynamic of human gut microbiota
Gut microbiota, the total microorganisms in our gastrointestinal tract, might have an implication in multiple sclerosis (MS), a demyelinating neurological disease. Our study included 50 MS patients and 21 healthy controls (HC). Twenty patients received a disease modifying therapy (DMT), interferon beta1a or teriflunomide, 19 DMT combined with homeopathy and 11 patients accepted only homeopathy. We collected in total 142 gut samples, two for each individual: at the study enrolment and eight weeks after treatment.
Source: Journal of Neuroimmunology - April 7, 2023 Category: Allergy & Immunology Authors: Vitalie Vacaras, Dafin F. Muresanu, Anca-Dana Buzoianu, Cristina Nistor, Stefan Cristian Vesa, Andreea Cristina Paraschiv, Daniela Botos-Vacaras, Cristiana Vacaras, George Vithoulkas Source Type: research

Influence of Diet in Multiple Sclerosis: A Systematic Review
Nutrition is considered to be a possible factor in the pathogenesis of the neurological disease multiple sclerosis (MS). Nutrition intervention studies suggest that diet may be considered as a complementary treatment to control the progression of the disease; a systematic review of the literature on the influence of diet on MS was therefore conducted. The literature search was conducted by using Medlars Online International Literature (MEDLINE) via PubMed and Scopus. Forty-seven articles met the inclusion criteria. The reviewed articles assessed the relations between macro- and micronutrient intakes and MS incidence. The p...
Source: Advances in Nutrition - May 15, 2017 Category: Nutrition Authors: Bagur, M. J., Murcia, M. A., Jimenez-Monreal, A. M., Tur, J. A., Bibiloni, M. M., Alonso, G. L., Martinez-Tome, M. Tags: Reviews Source Type: research

Mechanistic study on the possible role of embelin in treating neurodegenerative disorders
CNS Neurol Disord Drug Targets. 2023 Jan 19. doi: 10.2174/1871527322666230119100053. Online ahead of print.ABSTRACTEmbelin (EMB) (2,5-Dihydroxy-3-undecyl-1,4-benzoquinone) is a natural benzoquinone extracted mainly from Embelia ribes (ER) and appear as vivid orange dots beneath the fruit's pericarp. It is being used to treat various diseases since ancient times in India. It has been ascribed as one of the 32 ayurvedic drugs of national importance in the National Medicinal Plant Board set up by the Government of India under the Ministry of Indian System of Medicine and Homeopathy. Embelin prevents neuronal oxidative damage ...
Source: CNS and Neurological Disorders Drug Targets - January 19, 2023 Category: Drugs & Pharmacology Authors: None Anika Rimpi Arora Sharma Arvind Virendra Pooja A Chawla Source Type: research

Pages: 1  2